Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
10.1016/S1473-3099(21)00128-6
Saved in:
Similar Items
-
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
by: Natasha Howard, et al.
Published: (2023) -
Parental perceptions of childhood seasonal influenza vaccination in Singapore: A cross-sectional survey
by: Low M.S.F., et al.
Published: (2018) -
A social scientist's take on vaccine efficacy
by: Contreras, Antonio P.
Published: (2021) -
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children
by: Lum, L.C.S., et al.
Published: (2011) -
Circulating vaccine-derived poliovirus: A menace to the end game of polio eradication
by: Ming, L.C., et al.
Published: (2021)